首发精神分裂症患者葡萄糖稳态受损:系统综述与荟萃分析
该系统综述与荟萃分析纳入16项病例对照研究(731例患者、614例对照),评估未用药首发精神分裂症患者的葡萄糖稳态指标。结果显示空腹血糖、口服葡萄糖耐量试验后血糖、空腹胰岛素和胰岛素抵抗均显著升高,但HbA1c无显著差异,提示糖代谢异常从疾病早期即已存在。
要点
- 未用药首发精神分裂症患者已出现空腹血糖、OGTT后血糖、空腹胰岛素及胰岛素抵抗升高。
- HbA1c在患者与对照间无显著差异。
- 结果提示精神分裂症本身与糖尿病风险增加相关,应重视早期监测。
核心结论
- 精神分裂症患者从疾病起病即存在葡萄糖稳态改变,提示糖尿病风险增加。
研究设计与样本
- 系统综述与荟萃分析,检索EMBASE、MEDLINE和PsycINFO数据库,纳入16项病例对照研究(15个样本),共731例患者和614例对照。
主要发现
- 空腹血糖Hedges g=0.20(95%CI 0.02至0.38;P=.03),患者显著高于对照。
- 口服葡萄糖耐量试验后血糖Hedges g=0.61(95%CI 0.16至1.05;P=.007),患者显著高于对照。
- 空腹胰岛素Hedges g=0.41(95%CI 0.09至0.72;P=.01),患者显著高于对照。
- 胰岛素抵抗(HOMA-IR)Hedges g=0.35(95%CI 0.14至0.55;P=.001),患者显著高于对照。
- HbA1c Hedges g=-0.08(95%CI -0.34至0.18;P=.55),患者与对照无显著差异。
临床怎么用
- 临床应监测首发精神分裂症患者的血糖和胰岛素相关指标。
- 治疗选择时需考虑药物对糖代谢的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Schizophrenia is associated with an increased risk of type 2 diabetes. However, it is not clear whether schizophrenia confers an inherent risk for glucose dysregulation in the absence of the effects of chronic illness and long-term treatment. OBJECTIVE: To conduct a meta-analysis examining whether individuals with first-episode schizophrenia already exhibit alterations in glucose homeostasis compared with controls. DATA SOURCES: The EMBASE, MEDLINE, and PsycINFO databases were systematically searched for studies examining measures of glucose homeostasis in antipsychotic-naive individuals with first-episode schizophrenia compared with individuals serving as controls. STUDY SELECTION: Case-control studies reporting on fasting plasma glucose levels, plasma glucose levels after an oral glucose tolerance test, fasting plasma insulin levels, insulin resistance, and hemoglobin A1c (HbA1c) levels in first-episode antipsychotic-naive individuals with first-episode schizophrenia compared with healthy individuals serving as controls. Two independent investigators selected the studies. DATA EXTRACTION: Two independent investigators extracted study-level data for a random-effects meta-analysis. Standardized mean differences in fasting plasma glucose levels, plasma glucose levels after an oral glucose tolerance test, fasting plasma insulin levels, insulin resistance, and HbA1c levels were calculated. Sensitivity analyses examining the effect of body mass index, diet and exercise, race/ethnicity, and minimal (≤2 weeks) antipsychotic exposure were performed. DATA SYNTHESIS: Of 3660 citations retrieved, 16 case-control studies comprising 15 samples met inclusion criteria. The overall sample included 731 patients and 614 controls. Fasting plasma glucose levels (Hedges g = 0.20; 95% CI, 0.02 to 0.38; P = .03), plasma glucose levels after an oral glucose tolerance test (Hedges g = 0.61; 95% CI, 0.16 to 1.05; P = .007), fasting plasma insulin levels (Hedges g = 0.41; 95% CI, 0.09 to 0.72; P = .01), and insulin resistance (homeostatic model assessment of insulin resistance) (Hedges g = 0.35; 95% CI, 0.14 to 0.55; P = .001) were all significantly elevated in patients compared with controls. However, HbA1c levels (Hedges g = -0.08; CI, -0.34 to 0.18; P = .55) were not altered in patients compared with controls. CONCLUSIONS AND RELEVANCE: These findings show that glucose homeostasis is altered from illness onset in schizophrenia, indicating that patients are at increased risk of diabetes as a result. This finding has implications for the monitoring and treatment choice for patients with schizophrenia.
引用
- Pillinger T, Beck K, Gobjila C, et al. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017. PMID: 28097367. doi:10.1001/jamapsychiatry.2016.3803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。